-
The development, implementation and validation of a plasma-based high performance liquid chromatographic assay for Isoniazid and N-Acetylisoniazid: an acetylator status population study at Brewelskloof Hospital
-
The therapeutic importance of isoniazid metabolism in elderly patients
-
A critical appraisal of the clinical pharmacokinetics of isoniazid
-
Determinants and consequences of the pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in a cohort of tuberculosis patients
-
Safety of long-term isoniazid preventive therapy in children with HIV
-
Isoniazid Preventive Therapy Adherence and Associated Factors among HIV Positive Patients in Addis Ababa, Ethiopia
-
The impact of isoniazid preventative therapy and antiretroviral therapy on tuberculosis (TB) in HIV-infected children in a high TB incidence setting
-
Antiretroviral therapy adherence and effectiveness in a private sector disease management programme in Southern Africa
-
The Plasma, Whole Blood and Intracellular Concentrations of Antiretroviral Agents in South African Children Receiving Combination Antiretroviral Therapy with and without Concomitant Antitubercular Treatment
-
Outcomes of the three-month weekly isoniazid with rifapentine (3HP) versus the six-month isoniazid preventive therapy (6H) among people newly enrolled in HIV care in western Kenya
-
Isoniazid preventive therapy in HIV infected children on antiretroviral therapy living in a high tuberculosis prevalence area a randomized controlled trial
-
Isoniazid preventative therapy penetrance at a community health centre in South Africa: a cross sectional study
-
An assessment of the Isoniazid preventative therapy programme for children in a busy primary healthcare clinic in Nelson Mandela Bay, Eastern Cape Province
-
Perceptions of professional nurses about the barriers and enhancers to the implementation of isoniazid preventative therapy amongst HIV positive adults
-
The prevalence of isoniazid and rifampicin resistance of Mycobacterium tuberculosis
-
Risk factors associated with isoniazid resistance in tuberculosis
-
Deciphering the mechanisms of Isoniazid reisistance to mycobacterium tuberculosis
-
Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis
-
The efficacy of intermittent directly observed isoniazid in preventing tuberculosis in HIV-infected adults with advanced disease
-
Determination of biomarkers for toxicity and antiretroviral adherence in hair in South African patients
-
Completion of isoniazid preventive therapy and factors associated with non-completion in an antiretroviral therapy-naive HIV-infected cohort in Cape Town by Tolu Oni.
-
Determination of total, unbound, and intracellular concentrations of the antiretroviral drugs Efavirenz, Lopinavir, and Ritonavir
-
Differential expression of genes in clinical strains of mycobacterium tuberculosis in response to isoniazid
-
Determination of the mechanism of synergy of SQ109 with rifampicin and isoniazid in Mycobacterium smegmatis
